{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:08:46Z","timestamp":1793948926509,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.05.013","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T17:06:08Z","timestamp":1432055168000},"page":"3773-3778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Guillain-Barr\u00e9 syndrome and influenza vaccines: A meta-analysis"],"prefix":"10.1016","volume":"33","author":[{"given":"L.H.","family":"Mart\u00edn Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"S\u00e1inz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trece\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2015.05.013_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.013_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000339248","article-title":"Vaccine Safety Datalink Research Team. Guillain-Barr\u00e9 syndrome incidence in a large United States cohort (2000-2009)","volume":"39","author":"Shui","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"9","key":"10.1016\/j.vaccine.2015.05.013_bib0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","article-title":"Guillain-Barre syndrome after exposure to influenza virus","volume":"10","author":"Lehmann","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0020","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pone.0000344","article-title":"Guillain-Barre syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the General Practice Research Database","volume":"2","author":"Tam","year":"2007","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.013_bib0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2015.05.013_bib0030","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3201\/eid1212.051032","article-title":"Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barre syndrome, England","volume":"12","author":"Tam","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.013_bib0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/375845","article-title":"Guillain-Barre syndrome associated with Campylobacter jejuni infection in England, 2000\u20132001","volume":"37","author":"Tam","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.013_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11882-011-0190-y","article-title":"Guillain-Barr syndrome: modern theories of etiology","volume":"11","author":"Hardy","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"issue":"24","key":"10.1016\/j.vaccine.2015.05.013_bib0045","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barre syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.013_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11908-011-0194-8","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination: causal or coincidental?","volume":"13","author":"Sejvar","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"15","key":"10.1016\/j.vaccine.2015.05.013_bib0060","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0065","first-page":"657","article-title":"Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine \u2013 United States, 2009\u20132010","volume":"59","author":"Centers for Disease Control Prevention","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0070","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","article-title":"Guillain-Barr\u00e9 syndrome and the 1978\u20131979 influenza vaccine","volume":"304","author":"Hurwitz","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0075","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1982.03330060038030","article-title":"Guillain-Barr\u00e9 syndrome in the United States, 1979\u20131980 and 1980\u20131981. Lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"J Am Med Assoc"},{"issue":"25","key":"10.1016\/j.vaccine.2015.05.013_bib0080","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0085","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Guillain-Barr\u00e9 syndrome in the United Kingdom, 1992 to 2000","volume":"166","author":"Hughes","year":"2006","journal-title":"Arch Intern Med"},{"issue":"20","key":"10.1016\/j.vaccine.2015.05.013_bib0090","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain-Barr\u00e9 syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Intern Med"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2015.05.013_bib0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amepre.2010.05.022","article-title":"Evaluation of Guillain-Barr\u00e9 Syndrome among recipients of influenza vaccine in 2000 and 2001","volume":"39","author":"Burwen","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0100","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","article-title":"Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case\u2013control study in Europe","volume":"343","author":"Dieleman","year":"2011","journal-title":"Brit Med J"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.013_bib0105","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/aje\/kwr072","article-title":"Guillain-Barr\u00e9 syndrome, influenzalike illness, and influenza vaccination during seasons with and without circulating A\/H1N1 viruses","volume":"174","author":"Gimaldi-Bensouda","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0110","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1016\/j.vaccine.2011.08.069","article-title":"Guillain-Barr\u00e9 syndrome and H1N1 2009 pandemic influenza vaccination using an AS03 adyuvanted vaccine in the United Kingdom: self-controlled case series","volume":"29","author":"Andrews","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.05.013_bib0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/pds.3220","article-title":"The risk of Guillain-Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009\u20132010 seasonal influenza vaccines: results from self-controlled analyses","volume":"21","author":"Tokars","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"10.1016\/j.vaccine.2015.05.013_bib0120","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/aje\/kws197","article-title":"Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the post-licensure rapid immunization safety monitoring (PRISM) system, 2009\u20132010","volume":"175","author":"Yih","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2015.05.013_bib0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/aje\/kws195","article-title":"Risk of confirmed Guillain-Barr\u00e9 syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the vaccine safety datalink project, 2009\u20132010","volume":"175","author":"Greene","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2015.05.013_bib0130","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/aje\/kws196","article-title":"Guillain-Barr\u00e9 syndrome during 2009\u20132010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans","volume":"175","author":"Wise","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.013_bib0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2012.7342","article-title":"Risk of Guillain-Barr\u00e9 syndrome following H1N1 influenza vaccination in Quebec","volume":"308","author":"De Wals","year":"2012","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0140","doi-asserted-by":"crossref","first-page":"574","DOI":"10.5694\/mja12.10534","article-title":"Guillain-Barr\u00e9 syndrome following pandemic (H1N1) 2009 influenza A immunization in Victoria: a self-controlled case series","volume":"197","author":"Crawford","year":"2012","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.013_bib0145","doi-asserted-by":"crossref","first-page":"e58827","DOI":"10.1371\/journal.pone.0058827","article-title":"Safety of pandemic (H1N1) 2009 monovalent vaccines in Taiwan: a self-controlled case series study","volume":"8","author":"Huang","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10654-013-9797-8","article-title":"Risk of Guillain-Barr\u00e9 syndrome after 2010\u20132011 influenza vaccination","volume":"28","author":"Galeotti","year":"2013","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.013_bib0155","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/aje\/kwt051","article-title":"Chart-confirmed Guillain-Barr\u00e9 syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009\u20132010","volume":"178","author":"Polakowski","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.013_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain-Barr\u00e9 syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(13)70104-X","article-title":"Risk of Guillain-Barr\u00e9 syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study","volume":"13","author":"Kwong","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.05.013_bib0170","doi-asserted-by":"crossref","first-page":"e67185","DOI":"10.1371\/journal.pone.0067185","article-title":"Guillain-Barr\u00e9 syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009\u20132011","volume":"8","author":"Greene","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0175","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2013.10.031","article-title":"Evaluating the safety of influenza vaccine using a claims-based health system","volume":"31","author":"McCarthy","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.05.013_bib0180","doi-asserted-by":"crossref","first-page":"e82222","DOI":"10.1371\/journal.pone.0082222","article-title":"Guillain-Barr\u00e9 syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe","volume":"9","author":"Romio","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/pds.3575","article-title":"Absence of associations between influenza vaccines and increased risks of seizures. Guillain-Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012\u20132013 season","volume":"23","author":"Kawai","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0190","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2105\/AJPH.2013.301651","article-title":"Cumulative risk of Guillain-Barr\u00e9 syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic","volume":"104","author":"Vellozi","year":"2014","journal-title":"Am J Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2015.05.013_bib0195","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/pds.3638","article-title":"Risk of Guillain-Barr\u00e9 syndrome following pandemic influenza A (H1N1) 2009 vaccination in Germany","volume":"23","author":"Prestel","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0200","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.vaccine.2013.06.032","article-title":"International collaboration to assess the risk of Guillain Barr\u00e9 Syndrome following Influenza A (H1N1) 2009 monovalent vaccines","volume":"31","author":"Dodd","year":"2013","journal-title":"Vaccine"},{"issue":"9876","key":"10.1016\/j.vaccine.2015.05.013_bib0205","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2015.05.013_bib0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0215","series-title":"Cochrane handbook for systematic reviews of interventions, version 5.0.2","author":"Higgins","year":"2011"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0270","unstructured":"http:\/\/tech.cochrane.org\/revman\/download (accessed 17.01.15)."},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.013_bib0220","first-page":"354","article-title":"The PRISMA statement for reporting systematic reviews and meta-analysis of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"Ital J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2015.05.013_bib0225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12865-014-0061-0","article-title":"In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases","volume":"15","author":"McGarvey","year":"2014","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.013_bib0230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jns5.12074","article-title":"Genetics of Guillain-Barr\u00e9 syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions","volume":"19","author":"Blum","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0235","doi-asserted-by":"crossref","first-page":"c2649","DOI":"10.1136\/bmj.c2649","article-title":"Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months\u201312 years: open label, randomised, parallel group, multicentre study","volume":"340","author":"Waddington","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2015.05.013_bib0240","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2012.09.032","article-title":"Autoimmune disorders after immunisation with Influenza A\/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review","volume":"30","author":"Isai","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.05.013_bib0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barr\u00e9 syndrome","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.013_bib0250","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589624","article-title":"Anti-ganglioside antibody induction by swine (A\/NJ\/1976\/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barr\u00e9 syndrome","volume":"198","author":"Nachamkin","year":"2008","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2015.05.013_bib0255","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.vaccine.2012.02.009","article-title":"Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus","volume":"30","author":"Lei","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2015.05.013_bib0260","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2169\/internalmedicine.51.7132","article-title":"Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barr\u00e9 syndrome associated with H1N1 09 influenza vaccination","volume":"51","author":"Hoshino","year":"2012","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.vaccine.2015.05.013_bib0265","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:10:35Z","timestamp":1556349035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":54,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15006349"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain-Barr\u00e9 syndrome and influenza vaccines: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}